Skip to main content
. 2022 Nov 28;5(11):e2243857. doi: 10.1001/jamanetworkopen.2022.43857

Table 2. Standardized Mortality Ratios for Pediatric ALL in Sweden.

Characteristic Deaths among pediatric patients with ALL, No. Expected deaths in the general population, No. Standardized mortality ratio (95% CI)
Overall mortality
All 409 9.5 43.1 (39.0-47.5)
Females 171 3.0 57.8 (49.5-67.2)
Males 238 6.5 34.5 (32.0-41.4)
Age at ALL diagnosis, y
0-4 154 4.4 35.0 (29.7-41.0)
5-10 94 2.0 46.9 (37.9-57.4)
11-15 105 2.0 52.3 (42.8-63.4)
16-17 56 1.1 52.2 (39.4-67.7)
Date at ALL diagnosisa
1988-1991 56 0.5 114.8 (86.7-149.1)
1992-1999 91 0.8 111.8 (90.0-137.3)
2000-2007 90 0.7 132.6 (106.6-163.0)
2008-2013 71 0.7 109.3 (85.3-137.8)
Cause-specific mortality, ICD-10 chapterb
1 2 0.1 15.0 (1.8-54.2)
2
All 382 1.2 327.6 (295.5-362.1)
Females 161 0.5 334.7 (285.0-390.6)
Males 221 0.7 322.5 (281.4-368.0)
3 3 0.1 55.4 (11.4-161.8)
9 2 0.5 4.4 (0.5-16.0)
10 3 0.2 19.3 (4.0-56.3)
17 3 0.8 4.0 (0.8-11.6)
18 7 0.5 13.4 (5.4-27.7)
20 5 4.5 1.1 (0.4-2.6)
Specific cause of mortality
Hematologic malignant tumors
All 356 0.2 1551.1 (1394.1-1720.9)
Females 150 0.1 1878.4 (1589.9-2204.3)
Males 206 0.2 1376.4 (1198.5-1577.8)
Brain tumors 4 1.1 15.4 (4.2-39.3)

Abbreviations: ALL, acute lymphoblastic leukemia; ICD-10, International Statistical Classification of Diseases and Related Health Problems, Tenth Revision.

a

All patients had 4 years of follow-up except those who died during the study period.

b

ICD-10 chapters: 1, certain infectious and parasitic diseases; 2, neoplasms; 3, diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism; 9, diseases of the circulatory system; 10, diseases of the digestive system; 17, congenital malformations, deformations, and chromosomal abnormalities; 18, symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified; and 20, external causes of morbidity.